Spherix Global Insights

November 02, 2020

Ocrevus Still Reigns for Progressive MS, Spherix Reports, But Challenges Noted

From: Multiple Sclerosis News Today

By: Marta Figueiredo

 

 

Genentech’s Ocrevus (ocrelizumab) continues to be the most prescribed treatment for people with progressive forms of multiple sclerosis (MS) among U.S. neurologists, according to the latest Spherix Global Insights’ report…(read more).